mRNA vaccine technology for infectious diseases and beyond

被引：0
|
作者：
Pei Hao [1 ,2 ]
Xiao Li [3 ]
Xuan Li [4 ,2 ]
Wu Zhong [5 ]
机构：
[1] Key Laboratory of Molecular Virology and Immunology,Shanghai Institute of Immunity and Infection,Chinese Academy of Sciences
[2] University of Chinese Academy of Sciences
[3] Changchun Veterinary Research Institute,Chinese Academy of Agricultural Sciences
[4] Key Laboratory of Synthetic Biology,CAS Center for Excellence in Molecular Plant Sciences,Institute of Plant Physiology and Ecology,Chinese Academy of Sciences
[5] National Engineering Research Center for the Emergency Drug,Beijing Institute of Pharmacology and
来源：
ScienceChina(LifeSciences) | 2024年 / 67卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R392-33 [免疫学技术、设备及实验方法];
学科分类号：
摘要：
<正>The rise of mRNA vaccine technology Vaccines stand as one of the most significant medical advancements, playing a crucial role in the prevention of infectious diseases and the improvement of global health. The triumph of smallpox vaccination stands as a towering achievement in the annals of healthcare, leading to the complete elimination of a oncedevastating disease and showcasing the efficacy of vaccination methods.
引用
收藏
页码：2267 / 2270
页数：4
相关论文
共 50 条
  • [1] mRNA vaccine technology for infectious diseases and beyond
    Hao, Pei
    Li, Xiao
    Li, Xuan
    Zhong, Wu
    SCIENCE CHINA-LIFE SCIENCES, 2024, 67 (10) : 2267 - 2270
  • [2] Emerging Trends in mRNA Vaccine Technology: Beyond Infectious Diseases
    Khormi, Ali Hassan Ibrahim
    Qohal, Raied Mohammad Mosa
    Masrai, Abdulrahman Yahya Ahmed
    Hakami, Khaloufa Hassan Hofdallh
    Ogdy, Jaber Ahmed
    Almarshad, Abdu Ahmed
    Merai, Abdullah Mohammed Ahmed
    Harrisi, Hassan Suliman
    Alotaibi, Majed Mohammad
    Alotaibi, Abdulmajeed Mohammad
    Ghazi, Ahmed Ibrahim Ahmed
    Hejry, Abdullah Ali Abdu
    Akish, Hassan Mohammed Ismail
    Gharawy, Hasen Ali Hasen
    Fageh, Mottaen Darweesh Hasan
    EGYPTIAN JOURNAL OF CHEMISTRY, 2024, 67 (13): : 1567 - 1574
  • [3] mRNA as a Transformative Technology for Vaccine Development to Control Infectious Diseases
    Maruggi, Giulietta
    Zhang, Cuiling
    Li, Junwei
    Ulmer, Jeffrey B.
    Yu, Dong
    MOLECULAR THERAPY, 2019, 27 (04) : 757 - 772
  • [4] The mRNA vaccine development landscape for infectious diseases
    Arun Kumar
    Jeremy Blum
    Tung Thanh Le
    Nicolas Havelange
    Diletta Magini
    In-Kyu Yoon
    Nature Reviews Drug Discovery, 2022, 21 : 333 - 334
  • [5] The mRNA vaccine development landscape for infectious diseases
    Kumar, Arun
    Blum, Jeremy
    Thanh Le, Tung
    Havelange, Nicolas
    Magini, Diletta
    Yoon, In-Kyu
    NATURE REVIEWS DRUG DISCOVERY, 2022, 21 (05) : 333 - 334
  • [6] Vaccine development Progress in infectious diseases and beyond
    Louahed, Jamila
    European Pharmaceutical Review, 2024, 29 (03): : 54 - 55
  • [7] New Vaccine Technology for Control of Emerging and Reemerging Infectious Diseases
    Kang, Jin-Han
    EPIDEMIOLOGY AND HEALTH, 2006, 28 (01):
  • [8] mRNA-Based Nanomedicine: A New Strategy for Treating Infectious Diseases and Beyond
    Prakash, Satyendra
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2023, 48 (05) : 515 - 529
  • [9] mRNA-Based Nanomedicine: A New Strategy for Treating Infectious Diseases and Beyond
    Satyendra Prakash
    European Journal of Drug Metabolism and Pharmacokinetics, 2023, 48 : 515 - 529
  • [10] Vaccine and infectious diseases update
    Dedmon, Robert E.
    ASIAN BIOMEDICINE, 2008, 2 (06) : 511 - 513
12345